73 LamT.McLeanM.HaydenA.PoljakA.CheemaB.GurneyH.et al (2019)
Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, Ward CC, Cho K, Patti GJ, Nomura DK, et al
Third, although existing studies consistently demonstrate beneficial effects on hepatic steatosis and inflammation, the lack of head-to-head mechanistic and biomarker-based comparisons restricts the ability to distinguish between different GLP-1RAs or combination therapies in terms of their molecular pathways, immunemetabolic regulatory efficiency, and predictive biomarkers of therapeutic response
Acetyl L-carnitine crosses the blood-brain barrier, which may be relevant for patients needing brain antioxidant support